Status:

COMPLETED

Autologous Fat Augmentation of Orbital Volume Using a Closed Cannula Technique

Lead Sponsor:

Fox, Donald Munro, M.D., P.C.

Conditions:

Orbital Fat Atrophy

Eligibility:

All Genders

30-80 years

Phase:

NA

Brief Summary

After enucleation or evisceration with placement of a dermis fat graft or integrated orbital implant as a primary procedure, there can be secondary loss of orbital fat volume causing regression of per...

Detailed Description

To date, 5 subjects have completed fat injections and 4/5 have acquired complete sets of 3 MRIs each. Data analysis has begun. The study has been extended to include 5 more subjects (total 10) to incr...

Eligibility Criteria

Inclusion

  • Subjects who have developed secondary orbital fat atrophy after enucleation/evisceration with or without dermis fat grafting
  • standard sphere or integrated orbital implantation
  • phthisis bulbi are candidates

Exclusion

  • class 3 or greater anesthesia risk
  • infection
  • inability to follow study protocol

Key Trial Info

Start Date :

September 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 10 2017

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT01416233

Start Date

September 1 2010

End Date

December 10 2017

Last Update

August 20 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

New York Eye and Ear Infirmary

New York, New York, United States, 10003